Anavex Announces Executive Overseeing Regulatory Affairs

NEW YORK, NY – November 25, 2015 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, announces that Kristina M. Capiak, CCRP has been promoted the Company’s Vice President of…